Antibiotic resistance is a growing concern that threatens to return society to a pre-antibiotic era. The panel represents some of the leading clinician researchers and academic in Queensland who are working hard to rapidly diagnose superbugs and ensure that the right antibiotics are used to treat the right bacteria. This Global Leadership Series will touch on pandemics (Ebola) and other infectious diseases within the context of antibiotic resistant superbugs. UQ has received significant support to further research in this area through NHMRC, Wellcome Trust, and a variety of foundations and corporations.


Professor David Paterson
Group Leader, Infection & Immunity, UQ Centre for Clinical Research

David L. Paterson is a Professor of Medicine at The University of Queensland Centre for Clinical Research (UQCCR). He is also a Consultant Infectious Diseases Physician, Consultant Microbiologist and Medical Advisor for the Centre for Healthcare Related Infection Surveillance and Prevention (CHRISP).

Professor Paterson's clinical work, research and teaching has been honoured and recognised internationally. He received both his medical degree and PhD from The University of Queensland. In 2007, Professor Paterson returned to Brisbane after spending ten years at The University of Pittsburgh School of Medicine, one of the leading academic medical institutions in the United States. In 2000 he was one of two recipients of the prestigious American Society for Microbiology (ASM) Merck Irving Sigal Memorial Award for "Significant Research in Microbiology and Infectious Diseases". He received the 2008 Frank Fenner Award for Advanced Research in Infectious Diseases by the Australasian Society for Infectious Diseases (ASID) and in 2009 he was the winner of a Queensland Health Senior Clinical Research Fellowship.

Professor Mark Schembri

Professor Mark Schembri is an ARC Future Fellow in the School of Chemistry and Molecular Biosciences at UQ and the Deputy-Director of the Australian Infectious Disease Research Centre. Prof. Schembri’s research is focused on the study of surface proteins that mediate adhesion, aggregation, and biofilm formation, as these are the primary mechanisms used by bacteria to initiate disease.

His research papers have been cited almost 4000 times and his H index is 35. Highlights include papers in leading journals such as Nature Structural & Molecular Biology, EMBO Journal, PNAS, PLoS Pathogens, Journal of Biological Chemistry, Molecular Microbiology and Cellular Microbiology. 

Professor Mark Walker

Professor Mark Walker is the Director of the Australian Infectious Disease Research Centre.

Prof. Walker’s research focuses on the mechanism by which the group A streptococcus (Streptococcus pyogenes; GAS) causes invasive disease, with the aim of developing GAS vaccines.

These diseases range from mild skin infections such as pharyngitis, scarlet fever, impetigo, and cellulitis, to severe diseases such as septicemia, streptococcal toxic shock syndrome, and necrotizing fasciitis.

GAS is one of the ten most infectious diseases worldwide and Indigenous Australians suffer the highest rates of affliction with GAS diseases in the world.





About Global Leadership Series

The Global Leadership Series (GLS) is a lively program of events for alumni and community members. Join us for lectures and discussions with the best of the best UQ-related speakers on matters that impact your community and shape your ideas of the world.

The series is an opportunity for you to engage with great minds on global matters, participate in thought-provoking discussions and network with UQ alumni and community members. All alumni, parents, community members and friends are welcome to attend the Global Leadership Series events.

Listen to podcasts of previous GLS events click here


Customs House, 399 Queen St, Brisbane